Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'alpha 2 plasmin inhibitor' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 126 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lijnen, HR
      Gene targeting in hemostasis. Alpha(2)-antiplasmin

      FRONTIERS IN BIOSCIENCE
    2. Asakura, H; Ontachi, Y; Mizutani, T; Kato, M; Ito, T; Saito, M; Morishita, E; Yamazaki, M; Suga, Y; Miyamoto, KI; Nakao, S
      Depressed plasma activity of plasminogen or alpha 2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation

      BLOOD COAGULATION & FIBRINOLYSIS
    3. Lijnen, HR; Van Hoef, BT; Collen, D
      Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    4. Kushimoto, S; Yamamoto, Y; Shibata, Y; Sato, H; Koido, Y
      Implications of excessive fibrinolysis and alpha(2)-plasmin inhibitor deficiency in patients with severe head injury

      NEUROSURGERY
    5. Asakura, H; Ontachi, Y; Mizutani, T; Kato, M; Saito, M; Kumabashiri, I; Morishita, E; Yamazaki, M; Aoshima, K; Nakao, S
      An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation

      CRITICAL CARE MEDICINE
    6. Wilmer, M; Rudin, K; Kolde, HJ; Poetzsch, B; Lenz, W; Moessmer, G; Meili, E; Egbring, R; Gempeler-Messina, P; Gempeler, M; Bastian, S; Kohler, HP
      Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency

      THROMBOSIS RESEARCH
    7. Favier, R; Aoki, N; de Moerloose, P
      Congenital alpha(2)-plasmin inhibitor deficiencies: a review

      BRITISH JOURNAL OF HAEMATOLOGY
    8. Lijnen, HR; Ugwu, F; Maquoi, E; Lemmens, G; Van Hoef, B; Dewerchin, M; Collen, D
      Vascular and cellular proteolytic activity in mice with alpha(2)-antiplasmin gene inactivation

      FIBRINOLYSIS & PROTEOLYSIS
    9. Booth, NA
      Regulation of fibrinolytic activity by localization of inhibitors to fibrin(ogen)

      FIBRINOLYSIS & PROTEOLYSIS
    10. Schense, JC; Bloch, J; Aebischer, P; Hubbell, JA
      Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension

      NATURE BIOTECHNOLOGY
    11. Lorand, L
      Sol Sherry Lecture in thrombosis - Research on clot stabilization providesclues for improving thrombolytic therapies

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    12. Lijnen, HR; Collen, D
      Molecular basis of thrombolytic therapy

      JOURNAL OF NUCLEAR CARDIOLOGY
    13. Bick, RL
      Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy, and gynecology - Objective criteria for diagnosis and management

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    14. Saha, N; Aston, CE; Low, PS; Kamboh, MI
      Racial and genetic determinants of plasma factor XIII activity

      GENETIC EPIDEMIOLOGY
    15. Schroder, V; Kohler, HP
      Effect of factor XIII Val34Leu on alpha(2)-antiplasmin incorporation into fibrin

      THROMBOSIS AND HAEMOSTASIS
    16. Bangert, K; Thorsen, S
      Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis

      THROMBOSIS AND HAEMOSTASIS
    17. Yoshinaga, H; Hirosawa, S; Chung, DH; Miyasaka, N; Aoki, N; Favier, R
      A novel point mutation of the splicing donor site in the intron 2 of the plasmin inhibitor gene

      THROMBOSIS AND HAEMOSTASIS
    18. Chandler, WL; Alessi, MC; Aillaud, MF; Vague, P; Juhan-Vague, I
      Formation, inhibition and clearance of plasmin in vivo

      HAEMOSTASIS
    19. Ichinose, A; Souri, M; Izumi, T; Takahashi, N
      Molecular and genetic mechanisms of factor XIII A subunit deficiency

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    20. Hevessy, Z; Patthy, A; Karpati, L; Muszbek, L
      alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: An in vitro study

      THROMBOSIS RESEARCH
    21. Chung, DH; Ohashi, K; Watanabe, M; Miyasaka, N; Hirosawa, S
      Mannose trimming targets mutant alpha(2)-plasmin inhibitor for degradationby the proteasome

      JOURNAL OF BIOLOGICAL CHEMISTRY
    22. Ritchie, H; Lawrie, LC; Crombie, PW; Mosesson, MW; Booth, NA
      Cross-linking of plasminogen activator inhibitor 2 and alpha(2)-antiplasmin to fibrin(ogen)

      JOURNAL OF BIOLOGICAL CHEMISTRY
    23. Robinson, BR; Houng, AK; Reed, GL
      Catalytic life of activated factor XIII in thrombi - Implications for fibrinolytic resistance and thrombus aging

      CIRCULATION
    24. Robbie, LA; Bennett, B; Keyt, BA; Booth, NA
      Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha(2)-antiplasmin

      BRITISH JOURNAL OF HAEMATOLOGY
    25. Schense, JC; Hubbell, JA
      Cross-linking exogenous bifunctional peptides into fibrin gels with factorXIIIa

      BIOCONJUGATE CHEMISTRY
    26. Matsuzaki, K; Matsui, K; Tanoue, Y; Nagano, I; Haraguchi, N; Tatewaki, H
      Antifibrinolytic therapy with tranexamic acid in cardiac operations

      CARDIOVASCULAR SURGERY
    27. Clason, SB; Meijer, P; Kluft, C; Ersdal, E
      Specific determination of plasmin inhibitor activity in plasma: documentation of specificity of manual and automated procedures.

      BLOOD COAGULATION & FIBRINOLYSIS
    28. Muller-Berghaus, G; ten Cate, H; Levi, M
      Disseminated intravascular coagulation: Clinical spectrum and established as well as new diagnostic approaches

      THROMBOSIS AND HAEMOSTASIS
    29. Bick, RL; Arun, B; Frenkel, EP
      Disseminated intravascular coagulation - Clinical and pathophysiological mechanisms and manifestations

      HAEMOSTASIS
    30. Carli, P; Gisserot, O; Marlier, S; Paris, JF; Emmerich, J
      Heart-breaking hematomas

      REVUE DE MEDECINE INTERNE
    31. Kruse, P; Hage, E; Lasson, A
      Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats

      INTERNATIONAL JOURNAL OF PANCREATOLOGY
    32. Fujimoto, T; Nakamura, K; Nishihira, J
      Development of a latex immunoturbidimetric assay for the automated measurement of alpha(2) plasmin inhibitor-plasmin complex in human plasma

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    33. Kruse, P; Lasson, A; Hage, E
      Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats

      JOURNAL OF SURGICAL RESEARCH
    34. Reed, GL; Houng, AK
      The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism

      CIRCULATION
    35. Lind, B; Thorsen, S
      A novel missense mutation in the human plasmin inhibitor (alpha(2)-antiplasmin) gene associated with a bleeding tendency

      BRITISH JOURNAL OF HAEMATOLOGY
    36. Lee, KN; Tae, WC; Jackson, KW; Kwon, SH; McKee, PA
      Characterization of wild-type and mutant alpha(2)-antiplasmins: Fibrinolysis enhancement by reactive site mutant

      BLOOD
    37. Lijnen, HR; Okada, K; Matsuo, O; Collen, D; Dewerchin, M
      alpha(2)-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding

      BLOOD
    38. Lorand, L; Velasco, PT; Murthy, SNP; Lefebvre, P; Green, D
      Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner

      BLOOD
    39. MEIJER K; SMID WM; GEERARDS S; VANDERMEER J
      HYPERFIBRINOGENOLYSIS IN DISSEMINATED ADENOCARCINOMA

      Blood coagulation & fibrinolysis
    40. LEE KN; LEE SC; JACKSON KW; TAE WC; SCHWARTZOTT DG; MCKEE PA
      EFFECT OF PHENYLGLYOXAL-MODIFIED ALPHA(2)-ANTIPLASMIN ON UROKINASE-INDUCED FIBRINOLYSIS

      Thrombosis and haemostasis
    41. Devaussuzenet, VMP; Ducou-le-Pointe, HA; Doco, AM; Mary, PM; Montagne, JPR; Favier, R
      A case of intramedullary haematoma associated with congenital alpha(2)-plasmin inhibitor deficiency

      PEDIATRIC RADIOLOGY
    42. TATEMATSU M; HIGA A; SUNAGAWA H; IKEHARA O; SHIOHIRA Y
      DIALYSIS FOR A PATIENT WHO HAD CONGENITAL DEFICIENCY OF ALPHA(2)-PLASMIN INHIBITOR

      Clinical nephrology
    43. Bick, RL
      Disseminated intravascular coagulation: Pathophysiological mechanisms and manifestations

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    44. VALNICKOVA Z; ENGHILD JJ
      HUMAN PROCARBOXYPEPTIDASE-U, OR THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR, IS A SUBSTRATE FOR TRANSGLUTAMINASES - EVIDENCE FOR TRANSGLUTAMINASE-CATALYZED CROSS-LINKING TO FIBRIN

      The Journal of biological chemistry
    45. SUGO T; NAKAMIKAWA C; TAKEBE M; KOHNO I; EGBRING R; MATSUDA W
      FACTOR XIIIA CROSS-LINKING OF THE MARBURG FIBRIN - FORMATION OF ALPHA(M)CENTER-DOT-GAMMA(N)-HETEROMULTIMERS AND THE ALPHA-CHAIN-LINKED ALBUMIN-CENTER-DOT-GAMMA COMPLEX, AND DISTURBED PROTOFIBRIL ASSEMBLY RESULTING IN ACQUISITION OF PLASMIN RESISTANCE RELEVANT TO THROMBOPHILA

      Blood
    46. KAMPER EF; KOPEIKINA L; MANTAS A; STEFANADIS C; TOUTOUZAS P; STAVRIDIS J
      TETRANECTIN LEVELS IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION AND THEIR ALTERATIONS DURING THROMBOLYTIC TREATMENT

      Annals of clinical biochemistry
    47. LEE SC; LEE KN; SCHWARTZOTT DG; JACKSON KW; TAE WC; MCKEE PA
      PURIFICATION OF HUMAN ALPHA(2)-ANTIPLASMIN WITH CHICKEN IGY SPECIFIC TO ITS CARBOXY-TERMINAL PEPTIDE

      Preparative biochemistry & biotechnology
    48. WALLACE EM; PERKINS SJ; SIM RB; WILLIS AC; FEIGHERY C; JACKSON J
      DEGRADATION OF CL-INHIBITOR BY PLASMIN - IMPLICATIONS FOR THE CONTROLOF INFLAMMATORY PROCESSES

      Molecular medicine
    49. HELLSTERN P; BEECK H
      CLINICAL-FEATURES AND TREATMENT OF HEREDITARY AND ACQUIRED PLASMIN INHIBITOR DEFICIENCY

      Infusionstherapie und Transfusionsmedizin
    50. GUERMAZI S; KHELIF A; CONARD J; ENNABLI S; DELLAGI K
      BLEEDING SYNDROM AND ISOLATED ALPHA-2 ANT IPLASMIN DEFICIENCY - A CASE-REPORT

      Pathologie et biologie
    51. OKADA K; LIJNEN HR; DEWERCHIN M; BELAYEW A; MATSUO O; COLLEN D; BERNAERTS R
      CHARACTERIZATION AND TARGETING OF THE MURINE ALPHA(2)-ANTIPLASMIN GENE

      Thrombosis and haemostasis
    52. REED GL
      FUNCTIONAL-CHARACTERIZATION OF MONOCLONAL-ANTIBODY INHIBITORS OF ALPHA-2-ANTIPLASMIN THAT ACCELERATE FIBRINOLYSIS IN DIFFERENT ANIMAL PLASMAS

      Hybridoma
    53. TOYOSAWA M; KASHIWAGI S; PEI W; FUJISAWA H; ITO H; NAKAMURA K
      ELECTROPHORETIC DEMONSTRATION OF HIGH-MOLECULAR-WEIGHT FIBRIN DEGRADATION PRODUCTS PERSISTING IN CHRONIC SUBDURAL HEMATOMAS

      Electrophoresis
    54. TAKAHASHI H; URANO T; TAKADA Y; NAGAI N; TAKADA A
      FIBRINOLYTIC PARAMETERS AS AN ADMISSION PROGNOSTIC MARKER OF HEAD-INJURY IN PATIENTS WHO TALK AND DETERIORATE

      Journal of neurosurgery
    55. HETTASCH JM; PEOPLES KA; GREENBERG CS
      ANALYSIS OF FACTOR-XIII SUBSTRATE-SPECIFICITY USING RECOMBINANT HUMANFACTOR-XIII AND TISSUE TRANSGLUTAMINASE CHIMERAS

      The Journal of biological chemistry
    56. PARAMESWARAN KN; CHENG XF; CHEN EC; VELASCO PT; WILSON JH; LORAND L
      HYDROLYSIS OF GAMMA-EPSILON ISOPEPTIDES BY CYTOSOLIC TRANSGLUTAMINASES AND BY COAGULATION-FACTOR XIII(A)

      The Journal of biological chemistry
    57. BUTTE AN; HOUNG AK; JANG IK; REED GL
      ALPHA(2)-ANTIPLASMIN CAUSES THROMBI TO RESIST FIBRINOLYSIS INDUCED BYTISSUE-PLASMINOGEN ACTIVATOR IN EXPERIMENTAL PULMONARY-EMBOLISM

      Circulation
    58. LEWIS KB; TELLER DC; FRY J; LASSER GW; BISHOP PD
      CROSS-LINKING KINETICS OF THE HUMAN TRANSGLUTAMINASE, FACTOR XIII[A(2)], ACTING ON FIBRIN GELS AND GAMMA-CHAIN PEPTIDES

      Biochemistry
    59. PAQUERON X; FAVIER R; RICHARD P; MAILLET J; MURAT I
      SEVERE POSTADENOIDECTOMY BLEEDING REVEALING CONGENITAL ALPHA(2) ANTIPLASMIN DEFICIENCY IN A CHILD

      Anesthesia and analgesia
    60. TAKAHASHI Y; TANAKA T; MINOWA H; OOKUBO Y; SUGIMOTO M; NAKAJIMA M; MIYAUCHI Y; YOSHIOKA A
      HEREDITARY PARTIAL DEFICIENCY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 ASSOCIATED WITH A LIFELONG BLEEDING TENDENCY

      International journal of hematology
    61. OKAJIMA K; UCHIBA M; MURAKAMI K; OKABE H; TAKATSUKI K
      DETERMINATION OF PLASMA SOLUBLE FIBRIN USING A NEW ELISA METHOD IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION

      American journal of hematology
    62. ROBBIE LA; BENNETT B; CROLL AM; BROWN PAJ; BOOTH NA
      PROTEINS OF THE FIBRINOLYTIC SYSTEM IN HUMAN THROMBI

      Thrombosis and haemostasis
    63. KOLEV K; KOMOROWICZ E; OWEN WG; MACHOVICH R
      QUANTITATIVE COMPARISON OF FIBRIN DEGRADATION WITH PLASMIN, MINIPLASMIN, NEUROPHIL LEUKOCYTE ELASTASE AND CATHEPSIN-G

      Thrombosis and haemostasis
    64. HEVESSY Z; HARAMURA G; BODA Z; UDVARDY M; MUSZBEK L
      PROMOTION OF THE CROSS-LINKING OF FIBRIN AND ALPHA(2)-ANTIPLASMIN BY PLATELETS

      Thrombosis and haemostasis
    65. LEEBEEK FWG; LOS P; KLUFT C
      A MONOCLONAL-ANTIBODY AGAINST THE COOH-TERMINAL SITE OF ALPHA(2)-ANTIPLASMIN REVEALS HETEROGENEITY IN THE NONPLASMINOGEN BINDING FORM OF ALPHA(2)-ANTIPLASMIN

      Fibrinolysis
    66. CLASON SB; MEIJER P; KLUFT C; ERSDAL E
      A NOVEL METHOD, COAMATIC(R) PLASMIN INHIBITOR, FOR THE SPECIFIC DETERMINATION OF PLASMIN INHIBITOR ACTIVITY IN PLASMA

      Fibrinolysis
    67. SHIELDS DA; SAHARAY M; TIMOTHYANTOINE C; PORTER JB; SCURR JH; SMITH PDC
      NEUTROPHIL CD11B EXPRESSION IN PATIENTS WITH VENOUS DISEASE

      Phlebology
    68. BICK RL
      DISSEMINATED INTRAVASCULAR COAGULATION - OBJECTIVE CLINICAL AND LABORATORY DIAGNOSIS, TREATMENT, AND ASSESSMENT OF THERAPEUTIC RESPONSE

      Seminars in thrombosis and hemostasis
    69. IKEMATSU S; FUKUTAKE K; AOKI N
      HETEROZYGOTE FOR PLASMIN INHIBITOR DEFICIENCY DEVELOPING HEMORRHAGIC TENDENCY WITH ADVANCING AGE

      Thrombosis research
    70. UENOMACHI H; SONODA M; MIYAUCHI T; HARUBYU N; NAGATA H; MIYAHARA K; SANADA JI; ARIMA T
      RELATIONSHIP BETWEEN INTRACORONARY THROMBOLYSIS AND FIBRINO-COAGULATION - SPECIAL REFERENCE TO TAT PIC AND FPA/PIC/

      Japanese Circulation Journal
    71. MIYAUCHI Y; MII Y; AOKI M; TAMAI S; TAKAHASHI Y; YOSHIOKA A
      OPERATIVE TREATMENT OF INTRAMEDULLARY HEMATOMA ASSOCIATED WITH CONGENITAL DEFICIENCY OF ALPHA(2)-PLASMIN INHIBITOR - A REPORT OF 3 CASES

      Journal of bone and joint surgery. American volume
    72. RUDCHENKO S; TRAKHT I; SOBEL JH
      COMPARATIVE STRUCTURAL AND FUNCTIONAL FEATURES OF THE HUMAN FIBRINOGEN ALPHA-C DOMAIN AND THE ISOLATED ALPHA-C FRAGMENT - CHARACTERIZATION USING MONOCLONAL-ANTIBODIES TO DEFINED COOH-TERMINAL A-ALPHA CHAIN REGIONS

      The Journal of biological chemistry
    73. SOBEL JH; GAWINOWICZ MA
      IDENTIFICATION OF THE ALPHA-CHAIN LYSINE DONOR SITES INVOLVED IN FACTOR XIII(A) FIBRIN CROSS-LINKING

      The Journal of biological chemistry
    74. VALNICKOVA Z; THOGERSEN IB; CHRISTENSEN S; CHU CT; PIZZO SV; ENGHILD JJ
      ACTIVATED HUMAN PLASMA CARBOXYPEPTIDASE-B IS RETAINED IN THE BLOOD BYBINDING TO ALPHA(2)-MACROGLOBULIN AND PREGNANCY ZONE PROTEIN

      The Journal of biological chemistry
    75. TAGUCHI O; GABAZZA EC; YOSHIDA M; YAMAKAMI T; KOBAYASHI H; SHIMA T
      HIGH PLASMA-LEVEL OF PLASMIN-ALPHA-2-PLASMIN INHIBITOR COMPLEX IS PREDICTOR OF POOR-PROGNOSIS IN PATIENTS WITH LUNG-CANCER

      Clinica chimica acta
    76. MATSUKA YV; MEDVED LV; MIGLIORINI MM; INGHAM KC
      FACTOR XIIIA-CATALYZED CROSS-LINKING OF RECOMBINANT ALPHA-C FRAGMENTSOF HUMAN FIBRINOGEN

      Biochemistry
    77. RIES M; ZENKER M; KLINGE J; KEUPER H; HARMS D
      AGE-RELATED DIFFERENCES IN A CLOT LYSIS ASSAY AFTER ADDING DIFFERENT PLASMINOGEN ACTIVATORS IN A PLASMA MILIEU IN-VITRO

      Journal of pediatric hematology/oncology
    78. BICK RL
      DISSEMINATED INTRAVASCULAR COAGULATION - OBJECTIVE CRITERIA FOR CLINICAL AND LABORATORY DIAGNOSIS AND ASSESSMENT OF THERAPEUTIC RESPONSE

      Clinical and applied thrombosis/hemostasis
    79. SOE G; KOHNO I; INUZUKA K; MATSUDA M
      A RAPID LATEX IMMUNOASSAY FOR THE DETECTION OF PLASMIN ALPHA(2)-PLASMIN INHIBITOR COMPLEX - UTILIZATION OF 2 MONOCLONAL-ANTIBODIES DIFFERENTIALLY RECOGNIZING RESPECTIVE COMPONENTS OF THE COMPLEX

      Blood coagulation & fibrinolysis
    80. LIJNEN HR; COLLEN D
      MECHANISMS OF PHYSIOLOGICAL FIBRINOLYSIS

      Bailliere's clinical haematology
    81. SHIMOKAWA M; YAMAZAKI R; KINOSHITA T
      ASSAY OF PLASMIN AND PLASMINOGEN ACTIVITY IN PLASMA USING A DETERGENTHAVING A LONG ALKYL CHAIN

      Analytical sciences
    82. DOMBRET H; SCROBOHACI ML; DANIEL MT; MICLEA JM; CASTAIGNE S; CHOMIENNE C; FENAUX P; DEGOS L
      IN-VIVO THROMBIN AND PLASMIN ACTIVITIES IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY

      Leukemia
    83. HALIM A; BHUIYAN AB; AZIM FA; KHATUN S; KANAYAMA N; ELMARADNY E; MAEHARA K; HIROSHI K; TERAO T
      BLOOD-COAGULATION AND FIBRINOLYSIS IN ECLAMPTIC PATIENTS AND THEIR CORRELATION WITH THE CLINICAL SIGNS

      Gynecologic and obstetric investigation
    84. REED GL; LUKACOVA D
      GENERATION AND MECHANISM OF ACTION OF A POTENT INHIBITOR OF FACTOR-XIII FUNCTION

      Thrombosis and haemostasis
    85. COLLEN D; LIJNEN HR
      MOLECULAR-BASIS OF FIBRINOLYSIS, AS RELEVANT FOR THROMBOLYTIC THERAPY

      Thrombosis and haemostasis
    86. CHRISTENSEN S; SOTTRUPJENSEN L; CHRISTENSEN U
      STOPPED-FLOW FLUORESCENCE KINETICS OF BOVINE ALPHA(2)-ANTIPLASMIN INHIBITION OF BOVINE MIDIPLASMIN

      Biochemical journal
    87. SUGIKI M; MARUYAMA M; YOSHIDA E; MIHARA H; KAMIGUTI AS; THEAKSTON RDG
      ENHANCEMENT OF PLASMA FIBRINOLYSIS IN-VITRO BY JARARHAGIN, THE MAIN HEMORRHAGIC METALLOPROTEINASE IN BOTHROPS-JARARACA VENOM

      Toxicon
    88. SVOBODA P; MEIER J; FREYVOGEL TA
      PURIFICATION AND CHARACTERIZATION OF 3 ALPHA-2-ANTIPLASMIN AND ALPHA-2-MACROGLOBULIN INACTIVATING ENZYMES FROM THE VENOM OF THE MEXICAN WEST-COAST RATTLESNAKE (CROTALUS-BASILISCUS)

      Toxicon
    89. VANBODEGRAVEN AA; TUYNMAN HARE; SCHOORL M; KRUISHOOP AM; BARTELS PCM
      FIBRINOLYTIC SPLIT PRODUCTS, FIBRINOLYSIS, AND FACTOR-XIII ACTIVITY IN INFLAMMATORY BOWEL-DISEASE

      Scandinavian journal of gastroenterology
    90. BENDIXEN E; HARPEL PC; SOTTRUPJENSEN L
      LOCATION OF THE MAJOR EPSILON-(GAMMA-GLUTAMYL)LYSYL CROSS-LINKING SITE IN TRANSGLUTAMINASE-MODIFIED HUMAN PLASMINOGEN

      The Journal of biological chemistry
    91. SAKHAROV DV; RIJKEN DC
      SUPERFICIAL ACCUMULATION OF PLASMINOGEN DURING PLASMA CLOT LYSIS

      Circulation
    92. SOBEL JH; TRAKHT I; WU HQ; RUDCHENKO S; EGBRING R
      ALPHA-CHAIN CROSS-LINKING IN FIBRIN(OGEN) MARBURG

      Blood
    93. LIJNEN HR; BACHMANN F; COLLEN D; ELLIS V; PANNEKOEK H; RIJKEN DC; THORSEN S
      MECHANISMS OF PLASMINOGEN ACTIVATION

      Journal of internal medicine
    94. OMORI H; IKEDA M
      INTRAVASCULAR HYPERCOAGULABILITY IN PATIENTS WITH RECENT BELLS-PALSY

      European archives of oto-rhino-laryngology
    95. MORI K; WADA Y; MIMURO J; MATSUDA M; YOSHIKUNI Y; KIMURA K; SAKATA Y
      EFFECT OF GLYCOSIDASE INHIBITORS ON THE BIOSYNTHESIS OF ALPHA-2-PLASMIN INHIBITOR AND ANTITHROMBIN-III IN HEP G2 CELLS

      Biochimica et biophysica acta. Molecular basis of disease
    96. SHIMOKAWA M; KINOSHITA T
      INCREASE IN THE RESISTANCE OF PLASMIN TO THE INACTIVATION BY ALPHA(2)-PLASMIN INHIBITOR ON INCUBATION

      Analytical sciences
    97. OKAJIMA K; KOHNO I; SOE G; OKABE H; TAKATSUKI K; BINDER BR
      DIRECT EVIDENCE FOR SYSTEMIC FIBRINOGENOLYSIS IN PATIENTS WITH ACQUIRED ALPHA-2-PLASMIN INHIBITOR DEFICIENCY

      American journal of hematology
    98. SUGAHARA Y; MIURA O; HIROSAWA S; AOKI N
      COMPOUND HETEROZYGOUS PROTEIN-C DEFICIENCY CAUSED BY 2 MUTATIONS, ARG-178 TO GLN AND CYS-331 TO ARG, LEADING TO IMPAIRED SECRETION OF MUTANT PROTEIN-C

      Thrombosis and haemostasis
    99. KOJIMA Y; URANO T; KOJIMA K; SERIZAWA K; TAKADA Y; TAKADA A
      THE SIGNIFICANT ENHANCEMENT OF FIBRINOLYSIS BY CALCIUM-ION IN A CELL-FREE SYSTEM - THE SHORTENING OF EUGLOBULIN CLOT LYSIS TIME BY CALCIUM-ION

      Thrombosis and haemostasis
    100. BEER JH; KLAY HP; HERREN T; HAEBERLI A; STRAUB PW
      WHOLE-BLOOD CLOT LYSIS - ENHANCED BY EXPOSURE TO AUTOLOGOUS BUT NOT TO HOMOLOGOUS PLASMA

      Thrombosis and haemostasis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 00:17:16